The toll from a nationwide outbreak of fungal meningitis continued to rise Thursday, with 170 cases reported, including 14 deaths, according to the U.S. Centers for Disease Control and Prevention.
The CDC also warned that people who got injections of the recalled lots of steroid medicine, methylprednisolone acetate, in their knees and other joints could develop septic arthritis.
At the epicenter of the outbreak, infectious disease specialist Dr. Robert Latham is doing what he can for the 25 patients with fungal meningitis at Saint Thomas Hospital in Nashville.
His options are limited.
The two antifungal medicines in his arsenal -- voriconazole and amphotericin B -- have such vicious side effects that one carries the nickname "ampho-terrible." The drugs fight the fungus but can damage the liver and kidneys. They shouldn't be given, the CDC says, unless a patient's spinal fluid is clouded by infection.
Patients ill enough to receive the drugs can expect to be tethered to an intravenous drip for months.
Medical research provides little guidance for doctors and scant case history to predict the outcome.
"I don't think anybody in the country or the world, except for some very rare exceptions, has seen anything like this -- certainly not at the volume we're seeing now," Latham said.
But the drugs are showing results, said Latham.
"I can tell you with the people we've been treating the longest, we're seeing improvement in their spinal fluid," he said.
No preventive medicine
Dozens more people sick with worry come to the hospital wondering if the soreness in their necks is from tension or a first symptom of fungal meningitis -- something they may have contracted through tainted epidural spinal injections at the Saint Thomas Outpatient Neurosurgery Center on the hospital's ninth floor.Desperate to keep from getting ill, the patients from there and two other Tennessee pain clinics ask for preventive medicine.
"Do they not have something if this was to occur?" said Lourdes Gonzalez, who got her injections of the potentially contaminated steroid at the Specialty Surgery Center in Crossville.
But health officials say they know of nothing that can protect those exposed to the recalled drugs.
For people who show symptoms of the disease, a doctor will perform a spinal tap so the fluid can be tested for fungi linked to the outbreak. If the test turns out negative, the patient is sent home -- but without a clear bill of health. The pathogens can hide inside the spinal canal and not show up initially.
The CDC currently does not recommend prescribing the antifungals as a preventive measure. Some of the nation's top infectious disease experts have talked about the pros and cons of such an action, but they can only guess whether a pre-emptive strike would work.
"We would be going to Mars, in effect," said Dr. William Schaffner, a Vanderbilt professor who is president of the National Foundation for Infectious Disease.
Using the medicine in such a way could be potentially hazardous to patients, who may have gotten injections from a fungus-free vial, Shaffner said. And he said there's no proof that the treatment would keep people from getting sick.
Small chance of illness
Most people exposed to the possibly tainted drugs will not get fungal meningitis, health officials say -- although some may have better chances than others, depending on which lot of recalled medicine was used for their injections.Three lots of methylprednisolone acetate were recalled, but one has shown a higher "attack rate" than the other two, said Dr. David Reagan, chief medical officer for the Tennessee Department of Health.
Even for those receiving shots from that lot of medicine, the chance of illness is relatively small, Reagan said. "Currently, it changes, but it is a bit less than 5 percent of the people that have been exposed.
"Some lots have substantially less percentage than that."
Symptoms of meningitis include stiff neck, worsening headache or fever.
Infection of an arthritic joint, such as a knee, may be occurring if someone who got an injection suffers new or worsening pain with swelling, redness, and warmth at the injection site, according to the CDC.
Knowledge sharing
Scientists
and doctors are learning more about the outbreak day-by-day. At first,
only one type of fungus, Aspergillus, was thought to have contaminated
the steroid medicine. Over the weekend, the CDC said it had found a
second fungus. On Tuesday, the Tennessee Department of Health announced
that the majority of the cases in this state were actually from
Exserohilum, the second type of fungus.
Cases so far indicate that the antifungal medicines help people who are diagnosed and treated early, Dreyzehner said. "There is a balance here, though, because they are potentially very toxic medications."
The CDC is also advising doctors to prescribe antibacterials because they are not yet sure what contaminants may have been in the recalled medicine.
Latham and other doctors are looking to the CDC for better guidance on the use of the antifungals, particularly among older people with reduced kidney function, Dreyzehner said.
Experts are sharing their knowledge in conference calls. And the CDC has a team of scientists gathering outcome data, researching the scant accounts in medical literature about these rare illnesses and comparing notes on the best ways to use the medicine.
Said Schaffner: "Let's remember that we're in new territory."
